Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were easing late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each declining about 0.1%.The iShares Biotechnology ETF (IBB) ro
Top Midday Gainers
Corning (GLW) shares rose more than 13% in recent Monday trading after the company boosted guidance for Q2 core sales to $3.6 billion from $3.4 billion.More than 22 million of Corning's shares traded
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell sharply during Monday's session.Jefferies analyst Jonathan Matuszewski downgraded Arhaus from Buy to Hold and lowered the price target from $22 to $16.Arhaus
Pulse Stock Rallies 22% on FDA Breakthrough Designation
Pulse Biosciences (NASDAQ:PLSE) stock rallied 22% in morning trading Monday after the medtech company said it had received FDA breakthrough device designation for its CellFX nanosecond pulse field ablation cardiac surgery system for the treatment of atrial fibrillation, or AFib.
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index surging around 200 points on Monday.Shares of Corning Incorporated (NYSE:GLW) rose sharply during Monday's session after the company increased its sec
Express News | Pulse Biosciences Shares Are Trading Higher After the Company Announced It Received the Breakthrough Device Designation From the FDA for Its Cardiac Surgery System for the Ablation of Cardiac Tissue for the Treatment of Atrial Fibrillation
Pulse Biosciences Gets FDA's Breakthrough Status for Surgery System
By Dean Seal Pulse Biosciences said federal regulators have granted their breakthrough device designation for its cardiac surgery system for the ablation of cardiac tissue during atrial fibrillation.
Express News | Pulse Biosciences Receives FDA Breakthrough Device Designation For Cardiac Surgery System Using Nanosecond Pulsed Field Ablation Technology For Treating Atrial Fibrillation
Express News | Pulse Biosciences Inc - to Begin Pivotal Clinical Trial for Af in 2025
Express News | Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for Cellfx® Nspfa Cardiac Surgery System for the Treatment of Atrial Fibrillation
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX NsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
Provides expanded access to FDA and prioritized review of submissionMIAMI--(BUSINESS WIRE)--Jul. 8, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company lever
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
HAYWARD, Calif.--(BUSINESS WIRE)--Jul. 3, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed F
Pulse Biosciences Received Basic Subscriptions and Over-Subscriptions in Excess of $83M >PLSE
Pulse Biosciences Received Basic Subscriptions and Over-Subscriptions in Excess of $83M >PLSE
Express News | Pulse Biosciences Inc: Oversubscribed Offering Expected to Generate $60 Mln in Immediate Proceeds
Express News | Pulse Biosciences Inc - Warrants Could Generate up to $66 Million
Pulse Biosciences, Inc. Announces Preliminary Results for Its Rights Offering
Oversubscribed offering expected to generate $60 million in immediate gross proceeds for the Company Warrants issued in the offering could generate up to an additional $66MM HAYWARD, Calif.--(BUSINESS
A US$60m Drop in the Market Cap of Pulse Biosciences, Inc. (NASDAQ:PLSE) Is Not What Insiders Like to See After Purchasing Shares Recently
Pulse Biosciences Insiders Up US$3.3m On US$9.77m Investment
Insiders who bought Pulse Biosciences, Inc. (NASDAQ:PLSE) stock lover the last 12 months are probably not as affected by last week's 16% loss. After accounting for the recent loss, the US$9.77m worth
Pulse Biosciences, Inc. Announces Commencement of Rights Offering
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of SentinelOne, Inc. (NYSE:S) shares fell sharply during Friday's session after the company posted mixed first-quarter results.SentinelOne reported quarterly losses of 23 cents per share, which